Back to top
more

Zimmer Biomet (ZBH)

(Real Time Quote from BATS)

$109.04 USD

109.04
181,894

+0.86 (0.80%)

Updated Nov 11, 2024 10:42 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Zacks Analyst Blog Highlights: Comcast, ConocoPhillips, Delta Air Lines, ServiceNow and Zimmer Biomet

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Comcast, ConocoPhillips, Delta Air Lines, ServiceNow and Zimmer Biomet

Mark Vickery headshot

Top Research Reports for Comcast, ConocoPhillips & Delta Air Lines

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), ConocoPhillips (COP), and Delta Air Lines (DAL).

Zimmer Biomet (ZBH) Q3 Earnings Top Estimates, Margins Down

by Zacks Equity Research

We are encouraged by Zimmer Biomet's (ZBH) consistent effort in product renovation through research and development.

Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Zimmer (ZBH) delivered earnings and revenue surprises of 1.87% and 0.11%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Zimmer Biomet (ZBH) This Earnings Season?

by Zacks Equity Research

Focusing on areas like quality correction, supply recovery and product introductions, Zimmer Biomet (ZBH) is expected to see robust top-line numbers at S.E.T. arm in Q3.

Zimmer Biomet (ZBH) Q3 Earnings Preview: What's in the Cards?

by Zacks Equity Research

Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Drop

by Zacks Equity Research

The improvement within Zimmer Biomet's (ZBH) global Knee and Hip sales performance and ongoing growth within the Asia Pacific region are encouraging.

    Zimmer Biomet (ZBH) Beats on Q2 Earnings & Revenue Estimates

    by Zacks Equity Research

    Zimmer Biomet (ZBH) rides on strength in Knee and Hip segments in Q2.

      Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates

      by Zacks Equity Research

      Zimmer (ZBH) delivered earnings and revenue surprises of 2.13% and 0.65%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

        What's in the Cards for Zimmer Biomet (ZBH) in Q2 Earnings?

        by Zacks Equity Research

        Focusing on the thrust areas like quality correction, supply recovery efforts and product introductions, Zimmer Biomet (ZBH) is expected to retain robust top-line numbers within its S.E.T. arm.

          Zimmer Biomet (ZBH) Down 2.9% Since Earnings Report: Can It Rebound?

          by Zacks Equity Research

          Zimmer Biomet (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Zimmer Biomet New System Gets FDA Nod, to Boost Spine Wing

            by Zacks Equity Research

            Zimmer Biomet (ZBH) receives FDA's approval for the new system, which is likely to augment the company's lumbar spacers portfolio.

              Generac, Maximus, Norbord, Boeing and Zimmer Biomet as Zacks Bull and Bear of the Day

              by Zacks Equity Research

              Generac, Maximus, Norbord, Boeing and Zimmer Biomet as Zacks Bull and Bear of the Day

                Taye Baldinazzo headshot

                3 Stocks Back In Play After U.S.-China Trade War Stalls

                by Taye Baldinazzo

                On Sunday, the U.S. and China put trade tensions aside in hopes of reaching a stable and broad trade agreement. With previously at-risk stocks beginning to rise, there seems to be room for profit in these formerly questionable markets. Read on for three stocks that investors should reconsider as the trade war is put on hold.

                  Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, Margins Drop

                  by Zacks Equity Research

                  Zimmer Biomet (ZBH) issues full-year 2018 sales and earnings guidance in Q1.

                    Zimmer Biomet (ZBH) Beats on Q1 Earnings & Revenue Estimates

                    by Zacks Equity Research

                    Zimmer Biomet (ZBH) rides on strength in Knee, Hip and S.E.T. segments in Q1.

                      Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?

                      by Zacks Equity Research

                      Several FDA clearances within S.E.T since last November raise hope for Zimmer Biomet (ZBH) in Q1.

                        Supply Delay Hits Zimmer Biomet, Operational Plan Buoys Hope

                        by Zacks Equity Research

                        Zimmer Biomet's (ZBH) dull Knee sales continue to bother due to slower pace of supply recovery and sales recapture of certain key brands.

                          Urmimala Biswas headshot

                          Trade War Fears Grip MedTech: 3 Stocks on the Line of Fire

                          by Urmimala Biswas

                          Chances of a retaliation from China leads to widespread losses in the medical device sector.

                            New Strong Sell Stocks for February 1st

                            by Zacks Equity Research

                            Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                              Zimmer Biomet (ZBH) Q4 Earnings Meet, Sales Miss Estimates

                              by Zacks Equity Research

                              Zimmer Biomet (ZBH) rides high on all segments.

                                Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?

                                by Zacks Equity Research

                                Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q4.

                                  Zimmer Biomet Strong on Positive Data From PROGRESS II Study

                                  by Zacks Equity Research

                                  Zimmer Biomet (ZBH) consistently endeavors to improve its knee business.

                                    Zimmer Biomet (ZBH) Surges: Stock Moves 6.1% Higher

                                    by Zacks Equity Research

                                    Zimmer Biomet (ZBH) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

                                      New Strong Sell Stocks for December 12th

                                      by Zacks Equity Research

                                      Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: